Altium Wealth Management LLC Alaunos Therapeutics, Inc. Transaction History

Altium Wealth Management LLC

  • $1.39 Billion
  • Q2 2022

A detailed history of Altium Wealth Management LLC transactions in Alaunos Therapeutics, Inc. stock. As of the latest transaction made, Altium Wealth Management LLC holds 15,000 shares of TCRT stock, worth $29,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Previous 15,000 -0.0%
Holding current value
$29,400
Previous $10,000 90.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Jun 01, 2018
BUY
$4.0 - $6.54 $60,000 - $98,100
15,000
15,000 $62,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Altium Wealth Management LLC Portfolio

Follow Altium Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altium Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email